People are most likely to respond to rTMS if they have attempted less than 3 trials of antidepressants in the past, without success
Interestingly, the likelihood to respond (i.e., improve) with antidepressants is thought to decrease with every attempt. It is unclear whether someone’s past history with antidepressants affects the likelihood for someone to respond to rTMS or iTBS in the future. Knowing who might benefit most from neurostimulation therapies can help clinicians and patients understand the best treatment route for them.
Clinical Practice Guidelines for the Management of Depression
Depression is known to cause difficulty in daily functioning, self-esteem, sleep, and emotions. With all the research we’ve done with depression, guidelines are needed to organize this information into comprehensible and universal standards of care, informed by our most up-to-date understanding of diagnosis and treatment. The guideline in question comes from India in 2017 and is a keystone because it was the first to officially recommend the use of neuromodulatory treatments (specifically, electroconvulsive therapy; ECT) in severe cases of depression.
Patient Centered Research
Patient-Centred Research: New Research from the NINET Lab on the Side Effects Associated with rTMS One of the most critical aspects of clinical practice is to have up to date information on both the benefits and risks associated to a therapeutic intervention. They both equally important for patients and clinicians to inform decisions related to […]